Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy
October 21st, 2014
10.7K views
We describe how to visualize macrophage-C. neoformans (Cn) interactions in real time, with specific emphasis on the process of non-lytic exocytosis using digital light microscopy. Using this technique individually infected macrophages can be studied to ascertain various aspects of this phenomenon.
Overview
This study demonstrates a method to visualize the interactions between macrophages and Cryptococcus neoformans in real time, focusing on non-lytic exocytosis using digital light microscopy. The technique allows for the observation of infected macrophages over a 24-hour period to capture various exocytosis events.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Microbiology
Background
- Macrophages play a crucial role in the immune response against pathogens.
- Cryptococcus neoformans is a significant fungal pathogen that can evade immune responses.
- Non-lytic exocytosis is a process where macrophages expel pathogens without cell death.
- Digital light microscopy enables real-time visualization of cellular processes.
Purpose of Study
- To visualize non-lytic exocytosis of Cryptococcus neoformans from activated macrophages.
- To understand the dynamics of macrophage-fungal interactions.
- To document the variety of exocytosis types during infection.
Methods Used
- Primary bone marrow-derived macrophages were activated and infected with fungal cells.
- Extracellular fungal cells were removed to maintain a clear monolayer.
- Macrophages were incubated in a controlled environment for 24 hours.
- Digital light microscopy was used to capture and compile images into a movie.
Main Results
- Real-time visualization of non-lytic exocytosis events was successfully achieved.
- Various types of exocytosis were observed during the 24-hour infection period.
- The method provided insights into macrophage behavior in response to fungal infection.
- Digital light microscopy proved effective for studying cellular interactions.
Conclusions
- This technique enhances our understanding of macrophage interactions with pathogens.
- Non-lytic exocytosis is a significant mechanism in the immune response to Cryptococcus neoformans.
- The study contributes to the broader knowledge of macrophage functionality in infections.
Frequently Asked Questions
What is non-lytic exocytosis?
Non-lytic exocytosis is a process where macrophages expel pathogens without undergoing cell death.
Why is Cryptococcus neoformans significant?
It is a major fungal pathogen that can cause serious infections, particularly in immunocompromised individuals.
How does digital light microscopy aid in this research?
It allows for real-time visualization of cellular processes, enabling detailed observation of macrophage interactions.
What are the implications of this study?
The findings enhance our understanding of immune responses and may inform therapeutic strategies against fungal infections.
What type of macrophages were used in this study?
Primary bone marrow-derived macrophages were used, which are activated for the experiment.
How long were the macrophages observed?
The macrophages were observed for a 24-hour period to capture various exocytosis events.
Executive Industry Relevance
Visualizing non-lytic exocytosis of Cryptococcus neoformans from macrophages provides mechanistic insight into host-pathogen dynamics that can inform target validation in antifungal discovery. Real-time digital light microscopy enables quantitative tracking of pathogen release events without host cell lysis, supporting phenotypic screening and translational biomarker development. This approach enhances predictive confidence in preclinical models by capturing dynamic interactions missed in endpoint assays.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by visualizing pathogen expulsion mechanisms that leave both host and pathogen viable.
- Operational Value: Enables functional target validation through direct observation of exocytosis events over a 24-hour infection window.
- Predictive Value: Supports mechanistic de-risking by clarifying whether observed effects stem from lytic or non-lytic pathways.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream antifungal compound screening by establishing baseline exocytosis kinetics.
- Operational Value: Delivers quantitative, time-resolved outputs (e.g., event frequency, timing) suitable for assay standardization and reproducibility.
- Strategic Value: Enhances screening readiness by providing a dynamic readout that distinguishes between cytotoxic and non-cytotoxic mechanisms of action.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by using primary bone marrow-derived macrophages infected with clinically pertinent Cryptococcus neoformans strains.
- Operational Value: Ensures translational continuity from discovery through preclinical validation by capturing dynamic host-pathogen interactions over time.
- Risk-Adjusted Advancement: Informs go/no-go decisions by revealing whether test compounds alter exocytosis without inducing macrophage death.
Pipeline & Workflow Integration
The method fits within the discovery continuum from early target validation to lead identification, where dynamic visualization of non-lytic exocytosis supports hypothesis testing and biological de-risking before compound progression.
- Discovery Biology: Supports hypothesis testing by enabling direct observation of whether pathogens are expelled via lytic or non-lytic mechanisms.
- Screening: Delivers assay readiness through standardized, reproducible quantification of exocytosis events per macrophage over time.
- Analytics: Generates quantitative dependent variable measurements (e.g., exocytosis event count, latency) that allow comparison across experimental conditions.
- Translational Research: Connects to preclinical continuity by using primary macrophages and pathogenic fungal strains reflective of human infection contexts.
- Enterprise Reuse: Functions as a reusable imaging platform applicable to multiple host-pathogen systems beyond Cryptococcus neoformans.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in host-pathogen interaction studies.
- Operational Value: Promotes standardization and reproducibility through controlled environmental incubation and automated time-lapse imaging.
- Strategic Value: Improves capital efficiency by enabling early de-risking of compounds that inadvertently trigger lytic pathways and associated inflammation.
- Portfolio Impact: Supports risk-adjusted prioritization by identifying molecules that modulate exocytosis without compromising host cell viability.
Implementation Considerations
- Requires expertise in primary macrophage isolation, fungal pathogenesis, and live-cell imaging techniques.
- Dependent on stage-top incubators with precise CO2 and temperature control for 24-hour imaging.
- Necessitates standardized operating procedures for extracellular pathogen washing to ensure clear monolayers.
- Involves adaptation considerations when translating to other macrophage sources or pathogen species.
- Limited by phototoxicity risks over extended imaging periods, requiring optimization of light exposure and frame rate.
Biopharma FAQs
Why does null hypothesis testing matter for validating non-lytic exocytosis?
Null hypothesis testing determines whether observed pathogen release events exceed random movement or drift, establishing statistical significance for true exocytosis versus artifacts. This is critical for distinguishing biologically relevant events from background noise in time-lapse data.
How does isolating the independent variable (e.g., fungal strain) fit the discovery pipeline?
Isolating the fungal strain as the independent variable allows researchers to attribute changes in exocytosis frequency or timing specifically to pathogen characteristics, supporting target validation in early discovery. This control ensures that observed effects are not confounded by host variability.
What quantitative dependent variable measurements enable exocytosis analysis?
Dependent variables include the number of exocytosis events per macrophage, time-to-event after infection, and the number of yeast cells released per event. These metrics provide objective, quantifiable readouts for comparing conditions in screening campaigns.
Why do replication requirements matter for cross-functional collaboration?
Replication across multiple macrophages and experiments ensures that exocytosis observations are consistent and not due to stochastic variation, building confidence for handoff between discovery biology and assay development teams. Standardized replication supports assay transfer and inter-lab reproducibility.
What statistical analysis capabilities are required before implementing this imaging method?
Teams require capability to perform time-series analysis, event detection algorithms, and comparative statistical tests (e.g., t-tests or ANOVA) across conditions to determine significant differences in exocytosis dynamics. These analyses transform raw image sequences into actionable data for decision-making.
Chapters in this video
0:05
Title
1:27
Isolation and Preparation of Primary Bone Macrophages from C57/B16 Mice
4:51
Co‐incubation of Primary Murine Macrophages and C. neoformans
6:56
Visualizing Non‐lytic Exocytosis in Real‐time Utilizing Digital Light Microscopy
8:11
Results: Primary Murine Macrophages Undergo Different Types of Non‐lytic Exocytosis of C. neoformans
9:36
Conclusion
